Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 854,290 |
|
|||||
| News | - | ||||||
| Day High | 11.24 | Low High |
|||||
| Day Low | 10.445 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biomea Fusion Inc | BMEA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.21 | -1.91% | 10.77 | 18:11:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.00 | 10.445 | 11.24 | 10.77 | 10.98 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,052 | 854,290 | $ 10.86 | $ 9,278,866 | - | 8.125 - 43.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:08:31 | 2 | $ 11.24 | USD |
Biomea Fusion Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 384.91M | 35.71M | - | 0 | -117.26M | -3.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biomea Fusion News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BMEA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.09 | 12.10 | 10.22 | 11.07 | 1,016,396 | -1.32 | -10.92% |
| 1 Month | 15.14 | 16.29 | 10.22 | 12.77 | 1,035,438 | -4.37 | -28.86% |
| 3 Months | 17.81 | 20.21 | 10.22 | 15.65 | 1,057,995 | -7.04 | -39.53% |
| 6 Months | 10.52 | 22.74 | 8.125 | 14.97 | 1,158,059 | 0.25 | 2.38% |
| 1 Year | 30.64 | 43.69 | 8.125 | 18.51 | 903,582 | -19.87 | -64.85% |
| 3 Years | 16.52 | 43.69 | 2.84 | 18.42 | 441,686 | -5.75 | -34.81% |
| 5 Years | 20.00 | 43.69 | 2.84 | 18.41 | 443,192 | -9.23 | -46.15% |
Biomea Fusion Description
| Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. |
